JAKARTA – Today, the United States, through the U.S. Agency for International Development (USAID), and Indonesia’s Ministry of Health announced the award of a new tuberculosis program to strengthen Indonesia’s fight against TB and continue our progress toward eliminating TB by 2030.
Together Towards Elimination and Freedom From TB (USAID BEBAS TB) is a five-year, $70 million TB flagship activity to improve the quality of tuberculosis case detection, diagnosis, care, and prevention.
“USAID is pleased to partner with the Ministry of Health to improve health outcomes for the people of Indonesia, including for tuberculosis,” said Michael Schiffer, Assistant Administrator of USAID’s Bureau for Asia. “This new initiative demonstrates USAID’s commitment to our partnership in the ongoing fight against this terrible disease.”
Through the USAID BEBAS TB activity, USAID will provide technical assistance to the National TB Program to improve the quality of TB service delivery by introducing and piloting new approaches and treatment regimens, and bringing international best practices to Indonesia.
“The collaboration provided by the United States in supporting healthcare transformation in Indonesia has been instrumental. This includes the latest USAID support for tuberculosis control that will greatly contribute to Indonesia’s effort to achieve the TB elimination target by 2030,” said Minister of Health Budi G. Sadikin.
USAID BEBAS TB will support the government of Indonesia at the national level and focus on four densely populated provinces with high TB burdens: North Sumatra, West Java, Central Java, and East Java. The initiative will improve TB care in both public and private hospitals by enhancing the knowledge and skills of health care workers and community health workers.